We read with interest the study reported by Collin et al . [1], who carried out a survey on organisation and priorities of national tuberculosis (TB) programmes in Europe. With an estimated annual incidence of 10 million cases, TB is considered one of the three global infectious disease priorities, together with HIV/AIDS and malaria. However, TB incidence has significantly declined in the general European population during the past two decades, with a relative increase in vulnerable groups [2, 3]. The majority of patients completing anti-tuberculosis treatment have sequelae and benefit from pulmonary rehabilitation <http://ow.ly/WyOH30nFQLV> This article belongs to the scientific activities of the WHO Collaborating Centre for Tuberculosis and Lung Diseases, Tradate, ITA-80, 2017-2020- GBM/RC/LDA and of the GTN (Global Tuberculosis Network) Working Group on TB and Pulmonary Rehabilitation, TB Treatment Committee (Chair: Marcela Muňoz Torrico).
No takes yet. Share an insight, caveat, or question.
Visca et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: